Enpath Medical competitors

Zippia score 3.9

Enpath Medical main competitors are Cardiac Pacemakers, Inc, Endologix, and Freudenberg Medical.

Competitor Summary. See how Enpath Medical compares to its main competitors:

Cardiac Pacemakers, Inc has the most employees (2,500).
Employees at Cardiac Pacemakers, Inc earn more than most of the competitors, with an average yearly salary of $81,367.

Work at Enpath Medical?

Share your experience

Enpath Medical vs competitors

Company	Founding date	Zippia score	Headquarters	# of Locations	Revenue	Employees
Enpath Medical	1981	3.9	Plymouth, MN	1	$20.2M	200
LeMaitre	1983	4.6	Burlington, MA	3	$219.9M	457
Oscor	1982	4.2	Palm Harbor, FL	2	$28.9M	100
Cardiac Pacemakers, Inc	1971	4.1	Saint Paul, MN	1	$1.4B	2,500
EndoChoice	2008	4.4	Alpharetta, GA	1	$72.3M	501
CryoCor Inc	-		San Diego, CA	1	-	38
ADVANCED NEUROMODULATION SYSTEMS INC	-	3.9	Plano, TX	1	$100.1M	750
Gish Biomedical	1976	3.7	Rancho Santa Margarita, CA	1	$7.5M	100
Pace Medical	1985	3.4	San Diego, CA	1	$1.6M	10
Endologix	1992	4.7	Irvine, CA	2	$95.3M	488
Freudenberg Medical	1984	4.3	Carpinteria, CA	2	$300.0M	400

Rate Enpath Medical's competitiveness in the market.

Enpath Medical salaries vs competitors

Among Enpath Medical competitors, employees at Cardiac Pacemakers, Inc earn the most with an average yearly salary of $81,367.

Compare Enpath Medical salaries vs competitors

Company	Average salary	Hourly salary	Salary score
Enpath Medical	$64,819	$31.16	-
LeMaitre	$63,319	$30.44	-
Oscor	$48,170	$23.16	-
Cardiac Pacemakers, Inc	$81,367	$39.12	-
EndoChoice	$51,774	$24.89	-
Gish Biomedical	$64,838	$31.17	-

Compare Enpath Medical job title salaries vs competitors

Company	Highest salary	Hourly salary
Enpath Medical	$62,705	$30.15
Cardiac Pacemakers, Inc	$79,456	$38.20
Pace Medical	$69,026	$33.19
Oscor	$66,527	$31.98
Gish Biomedical	$65,649	$31.56
Endologix	$64,716	$31.11
CryoCor Inc	$64,679	$31.10
ADVANCED NEUROMODULATION SYSTEMS INC	$63,996	$30.77
LeMaitre	$63,695	$30.62
EndoChoice	$63,367	$30.46
Freudenberg Medical	$63,175	$30.37

Do you work at Enpath Medical?

Is Enpath Medical able to compete effectively with similar companies?

Enpath Medical jobs

Enpath Medical demographics vs competitors

Compare gender at Enpath Medical vs competitors

Job title	Male	Female
Endologix	55%	45%
LeMaitre	73%	27%
Gish Biomedical	73%	27%
Enpath Medical	-	-

Male

Female

100%

75%

50%

25%

25%

50%

75%

100%

Compare race at Enpath Medical vs competitors

Company	White	Hispanic or Latino	Black or African American	Asian	Unknown	Diversity score
Endologix	37%	21%	5%	32%	5%	9.3
LeMaitre	62%	13%	7%	13%	6%	8.1
Gish Biomedical	52%	17%	8%	14%	8%	6.6

Enpath Medical and similar companies CEOs

CEOBio

John Onopchenko

Endologix

John Onopchenko is a Board Member at Synecor, Board Member at Endologix Inc, and Chief Executive Officer at Endologix Inc. He has worked as Chief Operating Officer at VOLCANO CO., LTD.; Chief Operating Officer at Endologix Inc; and Exec VP:Strategy at VOLCANO CO., LTD.. John works or has worked as VP:Venture Investments at Johnson & Johnson Innovation - Jjdc Inc, Managing Director/Gen Partner at Synergy Life Sciences Partners, and MEMBER at FINRA. He studied at University of Chicago Booth School of Business and Ursinus College.

George D. Lemaitre M.d

LeMaitre

George Lemaitre is a Chairman/CEO at LEMAITRE VASCULAR INC, Manager at Lemaitre Family LLC, and Board Member at VASCUTECH INC and is based in Greater Boston Area. He has worked as Board Member at LEMAITRE VASCULAR INC, Credit Analyst at Connecticut National Bank/Bridgeport CT, and Associate at MCCOWN DE LEEUW & CO. George works or has worked as Board of Directors at LEMAITRE VASCULAR INC, Owner at LEMAITRE VASCULAR INC, and BOARD MEMBER at Stanford Univ Graduate Schl of Bussiness Management. He attended Stanford Graduate School of Business between 1990 and 1992, Phillips Academy Andover between 1978 and 1982, and Stanford University between 1982 and 1986.

Mark Gilreath

EndoChoice

Thomas Osypka

Oscor

Thomas Osypka is a President/CEO at Oscor Inc and Board Member at Micro Interventional Devices.